68-6
65/104

25) Miyoshi Y, Yorifuji T, Shimizu C, Nagasaki K, Kawai M, Ishiguro H, Okada S, Kanno J, Takubo N, Muroya K, Ito J, Horikawa R, Yokoya S, Ozono K: A nationwide question-naire survey targeting Japanese pediatric endocrinologists regarding transitional care in childhood, adolescent, and young adult cancer survivors. Clin Pediatr Endocrinol, 2020; 29: 55-62. 26) Izumita Y, Nishigaki S, Satoh M, Takubo N, Numakura C, Takahashi I, Soneda S, Abe Y, Kamasaki H, Ohtsu Y, Igaki J, Hasegawa Y, Nagasaki K: Retrospective study of the renal function using estimated glomerular filtra-tion rate and congenital anomalies of the kidney-urinary tract in pediatric Turner syndrome. Congenital Anomalies, 2020; 60: 175-179. 27) Tamune H, Kumakura Y, Morishima R, Kane-hara A, Tanaka M, Okochi N, Nakajima N, Hamada J, Ogawa a, Nakahara M, Jinde S, Kano Y, Tanaka K, Hirata Y, Oka A, Kasai K: Toward co-production of research in 22q11.2 deletion syndrome: Research needs from the caregiver’s perspective. Psychiatry Clin Neurosci, 2020; 74: 626-627. 28) Niizuma T, Obinata K, Kinoshita K, Shimizu T: Diagnostic usefulness of loop-mediated isothermal amplification intrafamilial pertussis infection. Juntendo Medical Journal, 2020; 66: 233-237. 29) Kudo T, Fujii T, Maisawa S, Sasaki M, Uchida K, Ida S, Kagimoto S, Yoden A, Shimizu T: A multicenter prospective survey on early-onset inflammatory bowel disease in Japan. Digestion, 2020; 18: 1-9. 30) Shoji H, Watanabe A, Awaji A, Ikeda N, Hosozawa M, Ohkawa N, Nishizaki N, Hisata K, Kantake M, Obinata K, Shimizu T: Intra-uterine growth restriction affects z-scores of anthropometric parameters during the first 6 years in very low-birth-weight-children born at less than 30 weeks of gestation. J Dev Orig Health Dis, 2020;11:44-48. 31) Shoji H, Taka H, Kaga N, Ikeda N, Hisata K, Miura Y, Shimizu T: Choline-related metabo-lites influenced by feeding patterns in preterm and term infants. J Matern Fetal Neonatal Med, 2020; 33: 230-235.for 32) Fujinaga S, Tomii Y: Profound effect of post- rituximab mycophenolate mofetil administra-tion for persistent hypogammaglobulinemia in young children with steroid-dependent nephrotic syndrome. Clin Exp Nephrol, 2020; 24: 386-387. 33) Fujinaga S, Umeda C: Risk factor for persistent proteinuria in adulthood after clinical remis-sion in Japanese children with immunoglob-ulin A nephropathy: impact of tonsillectomy combined with intravenous pulse methyl-prednisolone. Clin Exp Nephrol, 2020; 24: 734-735. 34) Fujinaga S, Mizutani A: Should rituximab be administered before cyclophosphamide as a first-line steroid-sparing agent to young children with steroid-dependent nephrotic syndrome?. Clin Exp Nephrol, 2020; 24: 1187-1188. 35) Fujinaga S, Watanabe Y, Nakagawa M: Effi-cacy of the novel selective β3-adrenoreceptor agonist vibegron for treatment-resistant mono-symptomatic nocturnal enuresis in children. Int J Urol, 2020; 27: 693-694. 36) Fujinaga S, Nishino T, Endo S, Umeda C, Watanabe Y, Nakagawa M: Unfavorable impact of anti-rituximab antibodies on clinical outcomes in children with complicated steroid- dependent nephrotic syndrome. Pediatr Nephrol, 2020; 35: 2003-2008. 37) Watanabe Y, Fujinaga S, Endo A, Endo S, Nakagawa M, Sakuraya K: Baseline charac-teristics and long-term outcomes of steroid- resistant nephrotic syndrome in children: impact of initial kidney histology. Pediatr Nephrol, 2020; 35: 2377-2381. 38) Sato S, Ohnishi T, Uejima Y, Furuichi M, Fujinaga S, Imai K, Nakamura K, Kawano Y, Suganuma E: Induction therapy with ritux-imab for lupus nephritis due to prolidase defi-ciency. Rheumatology (Oxford), 2020; 59: e57-e59. 39) Umeda C, Fujinaga S, Endo A, Sakuraya K, Asanuma S, Hirano D: Preventive effect of tonsillectomy on recurrence of Henoch-Schön-lein purpura nephritis after intravenous methylprednisolone pulse therapy. Tohoku J Exp Med, 2020; 250: 61-69. 40) Sigurdsson V, Haga Y, Takei H, Mansell E, 629

元のページ  ../index.html#65

このブックを見る